GLOBAL GLUTATHIONE MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION) TABLE 107
Updated 3/8/2021
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
At TrimRx, we often suggest that our members utilize supplemental support to bridge the gap during their treatment
Previous research has suggested that an imbalance in the action of ACE1 and ACE2 is a primary driver of COVID-19 pathophysiology
Desmopressin weighs only 1,069 daltons, well within the easy absorption range